Calendar of CURE/Yale BioHaven seminars for Fall 2010 now available. more
9/14
8:45 am - 6:00 pm

Ubifrance, the French Agency for international business development, cordially invites CURE members to this year's second French Biotech Tour, which aims to connect French and American Biotech companies specialized in neuroscience, inflammation, and auto-immune diseases. Philadelphia, PA. more
9/16
6:00 pm - 7:30 pm

CURE/Yale BioHaven presents Al Mann: 'Creating a successful medical device enterprise.' Hope Auditorium, Yale University, 315 Cedar Street, New Haven. more
10/5
Deadline for nominations for the Lemelson-MIT prize, awarded to an outstanding mid-career inventor who has developed a patented product or process of significant value to society. more
10/14
4:00 pm - 7:00 pm

Hartford Hospital Research Symposium. 'Personalized Medicine and Genomics: The Future is Now.' RSVP by 10/1 to 860.545.5620. Heublein Hall, Education & Resource Center, Hartford Hospital, Hudson Street, Hartford. more
10/27
4:00 pm - 6:00 pm

CURE/Yale BioHaven presents Cobalt Therapeutics. Anlyan Center, Yale University, 300 Cedar Street, New Haven. more
11/18
4:00 pm - 6:00 pm

CURE/Yale BioHaven presents Biodel Inc. Anlyan Center, Yale University, 300 Cedar Street, New Haven. more
12/7
5:30 pm - 7:30 pm

CURE Holiday Party. Café George, 300 George Street, New Haven. Watch for details.


GlaxoSmithKline
Moore Drive
PO Box 13398
Research Triangle Park, NC 27709

Phone: 860-870-1597
Website: http://www.gsk.com

Contact(s)
Paul Graml, Executive Manager, State Government Affairs

General Information
GlaxoSmithKline (GSK) is a world leading research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment. GSK's mission is to improve the quality of human life by enabling people to do more, feel better and live longer. Headquartered in the UK and with operations based in the U.S., the new company is one of the industry leaders, with an estimated seven percent of the world's pharmaceutical market. GSK also has leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS, respiratory and gastro-intestinal/metabolic. In addition, it is a leader in the important area of vaccines and has a growing portfolio of oncology products. The company also has a Consumer Healthcare portfolio comprising over-the-counter (OTC) medicines, oral care products and nutritional healthcare drinks, all of which are among the market leaders. The company has a leading position in genomics/genetics and new drug discovery technologies.

Back